Kelly E. Patrick

516 total citations
22 papers, 437 citations indexed

About

Kelly E. Patrick is a scholar working on Molecular Biology, Biochemistry and Pharmacology. According to data from OpenAlex, Kelly E. Patrick has authored 22 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Biochemistry and 6 papers in Pharmacology. Recurrent topics in Kelly E. Patrick's work include Polyamine Metabolism and Applications (7 papers), Inflammatory mediators and NSAID effects (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Kelly E. Patrick is often cited by papers focused on Polyamine Metabolism and Applications (7 papers), Inflammatory mediators and NSAID effects (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Kelly E. Patrick collaborates with scholars based in United States and United Kingdom. Kelly E. Patrick's co-authors include Susan M. Fischer, Gregory S. Cameron, Martha A. Belury, Mary Locniskar, Thomas J. Slaga, Laurel M. Adams, Juliette O’Connell, Andrew P. Butler, Claudio J. Conti and Mark Ward and has published in prestigious journals such as Brain Research, Journal of Investigative Dermatology and Carcinogenesis.

In The Last Decade

Kelly E. Patrick

22 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly E. Patrick United States 12 233 85 72 66 60 22 437
Tamara L. Casebolt United States 9 334 1.4× 36 0.4× 42 0.6× 59 0.9× 28 0.5× 11 614
Masako Watanabe Japan 14 272 1.2× 46 0.5× 52 0.7× 166 2.5× 22 0.4× 33 632
A.N. Makheja United States 12 209 0.9× 120 1.4× 31 0.4× 179 2.7× 79 1.3× 22 710
Si Young Cho South Korea 14 335 1.4× 86 1.0× 45 0.6× 41 0.6× 31 0.5× 22 645
Toshiko Suzuki-Yamamoto Japan 13 196 0.8× 56 0.7× 23 0.3× 94 1.4× 40 0.7× 33 479
Dagmar Szellas Germany 7 196 0.8× 60 0.7× 41 0.6× 184 2.8× 34 0.6× 7 507
Salvatore Cuzzocrea Italy 9 182 0.8× 48 0.6× 30 0.4× 38 0.6× 41 0.7× 9 527
Shim‐mo Hayashi Japan 14 228 1.0× 41 0.5× 108 1.5× 30 0.5× 33 0.6× 40 523
Filomena Silva Portugal 11 286 1.2× 41 0.5× 28 0.4× 62 0.9× 22 0.4× 20 563
Hyun-Ock Pae South Korea 8 210 0.9× 33 0.4× 41 0.6× 44 0.7× 16 0.3× 9 432

Countries citing papers authored by Kelly E. Patrick

Since Specialization
Citations

This map shows the geographic impact of Kelly E. Patrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly E. Patrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly E. Patrick more than expected).

Fields of papers citing papers by Kelly E. Patrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly E. Patrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly E. Patrick. The network helps show where Kelly E. Patrick may publish in the future.

Co-authorship network of co-authors of Kelly E. Patrick

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly E. Patrick. A scholar is included among the top collaborators of Kelly E. Patrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly E. Patrick. Kelly E. Patrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patrick, Kelly E. & Anthony P. Adams. (2021). Mobilization of Patients Receiving Extracorporeal Membrane Oxygenation Before Lung Transplant. Critical Care Nurse. 41(4). 39–45. 5 indexed citations
2.
Skljarevski, Vladimir, et al.. (2010). Efficacy and safety of duloxetine 60 mg once-daily in patients with chronic low back pain. Journal of Pain. 11(4). S38–S38. 4 indexed citations
3.
O’Neill, Michael J., Tracey K. Murray, Deborah R. McCarty, et al.. (2000). ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia. Brain Research. 871(2). 234–244. 40 indexed citations
4.
Cameron, Gregory S., et al.. (1992). Tumour promoter-induced release and metabolism of arachidonic acid: Comparison between mouse and human epidermal cells. Toxicology in Vitro. 6(2). 109–118. 4 indexed citations
5.
Locniskar, Mary, et al.. (1991). The effect of various dietary fats on skin tumor initiation. Nutrition and Cancer. 16(3-4). 189–196. 5 indexed citations
6.
Locniskar, Mary, et al.. (1991). The effect of the level of dietary corn oil on mouse skin carcinogenesis. Nutrition and Cancer. 16(1). 1–11. 11 indexed citations
7.
Locniskar, Mary, et al.. (1991). The effect of dietary lipid on skin tumor promotion by benzoyl peroxide: comparison of fish, coconut and corn oil. Carcinogenesis. 12(6). 1023–1028. 18 indexed citations
8.
Belury, Martha A., et al.. (1991). Modulation of phorbol ester-elicited events in mouse epidermis by dietary n-3 and n-6 fatty acids. Prostaglandins Leukotrienes and Essential Fatty Acids. 44(1). 19–26. 9 indexed citations
9.
Patrick, Kelly E., et al.. (1991). 4 Beta- and 4 alpha-12-O-tetradecanoylphorbol-13-acetate elicit arachidonate release from epidermal cells through different mechanisms.. PubMed. 51(3). 850–6. 26 indexed citations
10.
Cameron, Gregory S., et al.. (1990). Arachidonic Acid Metabolism Varies with the State of Differentiation in Density Gradient-Separated Mouse Epidermal Cells. Journal of Investigative Dermatology. 94(3). 292–296. 22 indexed citations
11.
Fischer, Susan M., et al.. (1990). Effects of antihistamines on phorbol ester tumor promotion and vascular permeability changes. Carcinogenesis. 11(6). 991–996. 18 indexed citations
12.
Locniskar, Mary, et al.. (1990). Lack of a protective effect of menhaden oil on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis. 11(9). 1641–1645. 16 indexed citations
13.
Fischer, Susan M., et al.. (1989). Mediation of phorbol ester-induced oxidant generation in murine epidermal cells by protein kinase C. Toxicology in Vitro. 3(3). 195–199. 2 indexed citations
15.
Fischer, Susan M., et al.. (1989). Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C.. PubMed. 49(23). 6693–9. 39 indexed citations
16.
Belury, Martha A., Kelly E. Patrick, Mary Locniskar, & Susan M. Fischer. (1989). Eicosapentaenoic and arachidonic acid: Comparison of metabolism and activity in murine epidermal cells. Lipids. 24(5). 423–429. 22 indexed citations
17.
Fischer, Susan M., et al.. (1988). Reactive oxygen in the tumor promotion stage of skin carcinogenesis. Lipids. 23(6). 592–597. 41 indexed citations
18.
Fischer, Susan M., et al.. (1988). Phorbol ester induction of 8-lipoxygenase in inbred SENCAR (SSIN) but not C57BL/6J mice correlated with hyperplasia, edema, and oxidant generation but not ornithine decarboxylase induction.. PubMed. 48(3). 658–64. 78 indexed citations
19.
Fischer, Susan M., et al.. (1987). Possible dissociation of the phorbol ester-induced oxidant response and tumor promotion in the F1 offspring of SSIN × C57BL/6J mice. Carcinogenesis. 8(10). 1521–1524. 6 indexed citations
20.
Fischer, Susan M., Juliette O’Connell, Claudio J. Conti, et al.. (1987). Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters. Carcinogenesis. 8(3). 421–424. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026